For example, we observed that 4 of the known drug targets (VDR, ALOX5AP, ITGA5, and ECE1) overlapped with genes that are differentially methylated only in the inflammatory SLE patients. The gene discussed is ITGA5; the disease is systemic lupus erythematosus.